Genetic variants of the human dipeptide transporter PEPT1

Journal of Pharmacology and Experimental Therapeutics

Volumn 316, Issue 2, 2006, Pages 636-646

  Anderle, Pascale ^a,b   Nielsen, Carsten Uhd ^c   Pinsonneault, Julia ^a   Krog, Pernille Lindskov ^c   Brodin, Birger ^c   Sadée, Wolfgang ^a,d  

^a OHIO STATE UNIVERSITY   (United States)

^b SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE TRANSPORTER 1;

ALLELE; ANIMAL CELL; ARTICLE; CELL STRAIN COS7; CHO CELL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG UPTAKE; EMBRYO; ETHNIC GROUP; EXON; EXPRESSION VECTOR; GENE CONTROL; GENE FREQUENCY; GENE SEQUENCE; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC TRANSFECTION; GENETIC VARIABILITY; HAPLOTYPE; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE BIOPSY; INTRON; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PH MEASUREMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA PROCESSING; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; TRANSCRIPTION INITIATION;

ANIMALS; BASE SEQUENCE; CERCOPITHECUS AETHIOPS; CHO CELLS; COS CELLS; CRICETINAE; CRICETULUS; DNA; HAPLOTYPES; HUMANS; INTESTINE, SMALL; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA SPLICING; RNA, MESSENGER; SYMPORTERS; TRANSFECTION;

EID: 31144449787     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.105.094615     Document Type: Article

References (32)

1. Aretz S, Uhlhaas S, Sun Y, Pagenstecher C, Mangold E, Caspari R, Moslein G, Schulmann K, Propping P, and Friedl W (2004) Familial adenomatous polyposis: aberrant splicing due to missense or silent mutations in the APC gene. Hum Mutat 24:370-380.
2. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
3. Bravo SA, Nielsen CU, Amstrup J, Frokjaer S, and Brodin B (2004) Epidermal growth factor decreases PEPT2 transport capacity and expression in the rat kidney proximal tubule cell line SKPT0193 cl.2. Am J Physiol 286:F385-F393.
4. Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, Shaw N, Lane CR, Lim EP, Kalyanaraman N, et al. (1999) Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet 22:231-238.
5. Chen XZ, Steel A, and Hediger MA (2000) Functional roles of histidine and tyrosine residues in the H()-peptide transporter PepT1. Biochem Biophys Res Commun 272:726-730.
6. Covitz KM, Amidon GL, and SadeeW(1996) Human dipeptide transporter, hPEPT1, stably transfected into Chinese hamster ovary cells. Pharm Res (NY) 13:1631-1634.
7. Dai Z and Sadee W (2005) Pharmacogenetics/genomics and personalized medicine. Hum Mol Genet 14 (Spec. No. 2):R207-R14.
8. Fei YJ, Liu JC, Fujita T, Liang R, Ganapathy V, and Leibach FH (1998) Identification of a potential substrate binding domain in the mammalian peptide transporters PEPT1 and PEPT2 using PEPT1-PEPT2 and PEPT2-PEPT1 chimeras. Biochem Biophys Res Commun 246:39-44.
9. Fei YJ, Liu W, Prasad PD, Kekuda R, Oblak TG, Ganapathy V, and Leibach FH (1997) Identification of the histidyl residue obligatory for the catalytic activity of the human H/peptide cotransporters PEPT1 and PEPT2. Biochemistry 36:452-460.
10. Ganapathy ME, Brandsch M, Prasad PD, Ganapathy V, and Leibach FH (1995) Differential recognition of beta-lactam antibiotics by intestinal and renal peptide transporters, PEPT 1 and PEPT 2. J Biol Chem 270:25672-25677.
11. Halushka MK, Fan JB, Bentley K, Hsie L, Shen N, Weder A, Cooper R, Lipshutz R, and Chakravarti A (1999) Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nat Genet 22:239-247.
12. Han H, de Vrueh RL, Rhie JK, Covitz KM, Smith PL, Lee CP, Oh DM, Sadee W, and Amidon GL (1998) 5′-Amino acid esters of antiviral nucleosides, acyclovir and AZT are absorbed by the intestinal PEPT1 peptide transporter. Pharm Res (NY) 15:1154-1159.
13. Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmoller J, Johne A, Cascorbi I, Gerloff T, Roots I, Eichelbaum M, and Brinkmann U (2000) Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 97:3473-3478.
14. Johnson AD, Wang D, and Sadee W (2005) Polymorphisms affecting gene regulation and mRNA processing: broad implications for pharmacogenetics. Pharmacol Ther 106:19-38.
15. Kennedy DJ, Leibach FH, Ganapathy V, and Thwaites DT (2002) Optimal absorptive transport of the dipeptide glycylsarcosine is dependent on functional Na/H exchange activity. Pflueg Arch Eur J Physiol 445:139-146.
16. Kulkarni AA, Haworth IS, Uchiyama T, and Lee VH (2003) Analysis of transmembrane segment 7 of the dipeptide transporter hPepT1 by cysteine-scanning mutagenesis. J Biol Chem 278:51833-51840.
17. Lee VH, Chu C, Mahlin ED, Basu SK, Ann DK, Bolger MB, Haworth IS, Yeung AK, Wu SK, Hamm-Alvarez S, and Okamoto CT (1999) Biopharmaceutics of transmucosal peptide and protein drug administration: role of transport mechanisms with a focus on the involvement of PepT1. J Control Release 62:129-140.
18. Licinio J and Wong ML (2002) Pharmacogenomics: The Search for Individualized Therapies. Wiley-VCH Verlag GmbH, Weinheim.
19. Miller SA, Dykes DD, and Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
20. Modrek B and Lee C (2002) A genomic view of alternative splicing. Nat Genet 30:13-19.
21. Nielsen CU, Amstrup J, Steffansen B, Frokjaer S, and Brodin B (2001) Epidermal growth factor inhibits glycylsarcosine transport and hPepT1 expression in a human intestinal cell line. Am J Physiol 281:G191-G199.
22. Phan DD, Chin-Hong P, Lin ET, Anderle P, Sadee W, and Guglielmo BJ (2003) Intraand interindividual variabilities of valacyclovir oral bioavailability and effect of coadministration of an hPEPT1 inhibitor. Antimicrob Agents Chemother 47:2351-2353.
23. Pinsonneault J, Nielsen CU, and Sadee W (2004) Genetic variants of the human H/dipeptide transporter PEPT2: analysis of haplotype functions. J Pharmacol Exp Ther 311:1088-1096.
24. Rockman MV and Wray GA (2002) Abundant raw material for cis-regulatory evolution in humans. Mol Biol Evol 19:1991-2004.
25. Saito H, Motohashi H, Mukai M, and Inui K (1997) Cloning and characterization of a pH-sensing regulatory factor that modulates transport activity of the human H/peptide cotransporter, PEPT1. Biochem Biophys Res Commun 237:577-582.
26. Stephens JC, Schneider JA, Tanguay DA, Choi J, Acharya T, Stanley SE, Jiang R, Messer CJ, Chew A, Han JH, et al. (2001) Haplotype variation and linkage disequilibrium in 313 human genes. Science (Wash DC) 293:489-493.
27. Tajima F (1989) Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 123:585-595.
28. Urtti A, Johns SJ, and SadeeW(2001) Genomic structure of proton-coupled oligopeptide transporter hPEPT1 and pH-sensing regulatory splice variant. AAPS Pharm-Sci 3:E6.
29. Wang D, Johnson AD, Papp A, Kroetz DL, and Sadee W (2005) Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability. Pharmacogenet Genomics 15:693-704.
30. Yan H, Yuan W, Velculescu VE, Vogelstein B, and Kinzler KW (2002) Allelic variation in human gene expression. Science (Wash DC) 297:1143.
31. Yeung AK, Basu SK, Wu SK, Chu C, Okamoto CT, Hamm-Alvarez SF, von Grafenstein H, Shen WC, Kim KJ, Bolger MB, et al. (1998) Molecular identification of a role for tyrosine 167 in the function of the human intestinal proton-coupled dipeptide transporter (hPepT1). Biochem Biophys Res Commun 250:103-107.
32. Zhang EY, Fu DJ, Pak YA, Stewart T, Mukhopadhyay N, Wrighton SA, and Hillgren KM (2004) Genetic polymorphisms in human proton-dependent dipeptide transporter PEPT1: implications for the functional role of Pro586. J Pharmacol Exp Ther 310:437-445.